发明名称 |
Individual 5-fluorouracile dose optimization in FOLFIRI treatment |
摘要 |
The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively optimizing the 5 -FU dose administered by continuous infusion in patients treated by a FOLFIRI regimen or a similar regimen, based on the 5 -FU plasmatic concentration measured during the previous 5 -FU continuous infusion and on a herein described decision algorithm. The present invention also relates to a method for treating a cancer patient in which the 5 -FU dose administered in continuous infusion in each FOLFIRI or similar treatment cycle is optimized using the decision algorithm according to the invention. |
申请公布号 |
AU2008362109(B2) |
申请公布日期 |
2015.08.27 |
申请号 |
AU20080362109 |
申请日期 |
2008.09.26 |
申请人 |
UNIVERSITE D'ANGERS;INSTITUT DE CANCEROLOGIE DE L'OUEST |
发明人 |
GAMELIN, ERICK;BOISDRON-CELLE, MICHELE;MOREL, ALAIN |
分类号 |
A61K31/4745;A61K31/513;A61K31/519;A61K39/395;A61P39/00 |
主分类号 |
A61K31/4745 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|